221
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Mapping Current Organizational Structure and Improvement Points of Breast Cancer Multidisciplinary Team Meetings – An Interview Study

ORCID Icon, , , , , & show all
Pages 2421-2430 | Received 06 Jul 2022, Accepted 16 Sep 2022, Published online: 21 Oct 2022

Figures & data

Table 1 An Overview of All Study Participant per Hospital. The Specialty of Nurse Specialists is Depicted Between Brackets

Table 2 Overview of MDTM Organizational Structure per Included Hospital

Figure 1 Summary of participant comments regarding the preparation of breast cancer MDTMs. (A) Duration of preparation: estimated average time spent preparing the MDTM per participant. (B) Preparation methods: the method of preparation used per participant. (C) Preparation remarks: comments regarding the preparation of colleagues. (D) Benefits of preparation: factors related to preparation that were considered beneficial for MDTMs.

Figure 1 Summary of participant comments regarding the preparation of breast cancer MDTMs. (A) Duration of preparation: estimated average time spent preparing the MDTM per participant. (B) Preparation methods: the method of preparation used per participant. (C) Preparation remarks: comments regarding the preparation of colleagues. (D) Benefits of preparation: factors related to preparation that were considered beneficial for MDTMs.

Table 3 List of Points of Improvement for Breast Cancer MDTMs as Stated by the Participants

Figure 2 Summary of participant comments regarding the facilitators and barriers of time management during breast cancer MDTMs. (A) Structure: facilitators and barriers concerning the structure of breast cancer MDTMs. (B) Availability of information: facilitators and barriers concerning patient information. (C) Meeting discipline: facilitators and barriers concerning the way MDTMs are moderated.

Figure 2 Summary of participant comments regarding the facilitators and barriers of time management during breast cancer MDTMs. (A) Structure: facilitators and barriers concerning the structure of breast cancer MDTMs. (B) Availability of information: facilitators and barriers concerning patient information. (C) Meeting discipline: facilitators and barriers concerning the way MDTMs are moderated.